Apolipoproteins A and B and PCSK9: Nontraditional Cardiovascular Risk Factors in Chronic Kidney Disease and in End-Stage Renal Disease
Purpose. Nontraditional cardiovascular risk factors as apolipoprotein A (ApoA), apolipoprotein B (ApoB), and the proprotein convertase subtilisin/kexin type 9 (PCSK9) increase the prevalence of cardiovascular mortality in chronic kidney disease (CKD) or in end-stage renal disease (ESRD) through quan...
Saved in:
Main Authors: | Cristiana-Elena Vlad, Liliana Foia, Roxana Popescu, Iuliu Ivanov, Mihaela Catalina Luca, Carmen Delianu, Vasilica Toma, Cristian Statescu, Ciprian Rezus, Laura Florea |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-01-01
|
Series: | Journal of Diabetes Research |
Online Access: | http://dx.doi.org/10.1155/2019/6906278 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hepatitis C Infection and Periodontal Disease: Is there a Common Immunological Link?
by: Dorin Nicolae Gheorghe, et al.
Published: (2018-01-01) -
Serum PCSK9 Correlates with PTX3 and Apolipoproteins B, A1, and C3 Concentrations in Patients with Type 2 Diabetes
by: Małgorzata Waluś-Miarka, et al.
Published: (2021-01-01) -
Multi-functional role of apolipoprotein E in neurodegenerative diseases
by: Sadequl Islam, et al.
Published: (2025-01-01) -
Research progress on the mechanisms of apolipoprotein E in Alzheimer’s disease
by: Jiayuan Li, et al.
Published: (2025-01-01) -
Mitochondrial Dysfunction and Diabetic Nephropathy: Nontraditional Therapeutic Opportunities
by: Ping Na Zhang, et al.
Published: (2021-01-01)